Mary Varghese

Statistics

Publications

Citations

1.2K

H-Index

Active since

2012

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Fondazione IRCCS Istituto Neurologico Carlo Besta

International University of Health and Welfare

University of North Carolina at Chapel Hill

Stanford University

Mary Varghese is an author at Alexion Pharmaceuticals (United States) specializing in myasthenia gravis pharmacotherapy, anti-acetylcholine receptor antibodies, and myasthenia gravis.

ORCID

Publications per year

2012–2020

Publications

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

College Student Cyberbullying: Self‐Esteem, Depression, Loneliness, and Attachment

Mary Varghese, M. Carole Pistole · Journal of College Counseling · 2017 · 138 citations

Social Sciences, Psychology, Social Psychology +12

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Experiential Internships: Understanding the Process of Student Learning in Small Business Internships

Mary Varghese, Loran Carleton Parker, Omolola A. Adedokun et al. · Industry and Higher Education · 2012 · 34 citations

Business, Entrepreneurship, Apprenticeship Education +10

1–5 of 8